| Identification | Back Directory | [Name]
(2R,3S,4S,5R,6R)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2S,3R)-3-hydrox y-2-(tetracosanoylamino)octadec-4-enoxy]-4-sulfooxy-oxane | [CAS]
151122-71-3 | [Synonyms]
C24 3&rsquo
-sulfo Galactosylceramide (d18:1/24:0)
C24 3'-sulfo Galactosylceramide (d18:1/24:0)
1-(3-O-sulfo-beta-D-galactosyl)-N-tetracosanoylsphingosine
Tetracosanamide, N-[(1S,2R,3E)-2-hydroxy-1-[[(3-O-sulfo-β-D-galactopyranosyl)oxy]methyl]-3-heptadecen-1-yl]-
(2R,3S,4S,5R,6R)-3,5-dihydroxy-2-(hydroxymethyl)-6-[(E,2S,3R)-3-hydrox y-2-(tetracosanoylamino)octadec-4-enoxy]-4-sulfooxy-oxane | [Molecular Formula]
C48H93NO11S | [MOL File]
151122-71-3.mol | [Molecular Weight]
892.32 |
| Chemical Properties | Back Directory | [density ]
1.09±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Chloroform:Methanol (5:1): soluble | [form ]
A solid | [pka]
-3.61±0.18(Predicted) |
| Hazard Information | Back Directory | [Uses]
Tetracosanoyl-sulfatide is an endogenous metabolite present in Urine that can be used for the research of Mild Metachromatic Leukodystrophy[1][2]. | [Definition]
ChEBI: A D-galactosyl-N-acylsphingosine having a sulfo group at the 3-position on the galactose ring and tetracosanoyl as the N-acyl group. | [storage]
Store at -20°C | [References]
[1] Lee N, et al. Endogenous toxic metabolites and implications in cancer therapy. Oncogene. 2020 Aug;39(35):5709-5720. DOI:10.1038/s41388-020-01395-9
[2] Natowicz MR, et al. Urine sulfatides and the diagnosis of metachromatic leukodystrophy. Clin Chem. 1996 Feb;42(2):232-8. PMID:8595716 |
|
| Company Name: |
Alfa Chemistry
|
| Tel: |
1-516-6625404 |
| Website: |
https://www.alfa-chemistry.com |
| Company Name: |
Enzo Biochem Inc
|
| Tel: |
Enzo Biochem Inc. 13797054060 |
| Website: |
www.enzo.com |
| Company Name: |
Abcam Limited
|
| Tel: |
021-2070050 400921018 |
| Website: |
www.abcam.cn |
|